Related Experiment Video
Updated: Jun 20, 2026

Comprehensive & Cost Effective Laboratory Monitoring of HIV/AIDS: an African Role Model
Published on: October 31, 2010
Timely and Efficient Infant Diagnosis Is Required to End AIDS in Children
1Global Health Impact Group, Atlanta, Georgia, USA.
Insights
Ending AIDS in children requires improved HIV case-finding and timely antiretroviral treatment (ART) initiation. Tailored strategies and innovative testing are crucial for identifying and treating children living with HIV.
Area of Science:
- Pediatric infectious diseases
- Global public health
- HIV/AIDS epidemiology
Background:
- Despite progress, over 70,000 children die annually from AIDS-related illnesses.
- Nearly half of the 1.4 million children living with HIV are not receiving antiretroviral treatment (ART).
- Effective case-finding and ART linkage are vital to eliminate pediatric AIDS.
Purpose of the Study:
- To highlight the need for improved strategies in identifying and treating children living with HIV.
- To emphasize the importance of timely ART initiation for pediatric HIV management.
- To discuss innovative approaches for ending AIDS in children.
Main Methods:
- Review and adaptation of existing infant and child case-finding strategies.
- Integration of HIV testing into various healthcare settings (malnutrition wards, inpatient units, vaccination clinics).
- Implementation of out-of-facility testing, including community and family-based approaches.
Main Results:
- Repeated testing is critical throughout the HIV exposure period, including post-breastfeeding, to capture early infections.
- Same-day point-of-care testing technologies enable immediate or rapid linkage to ART.
- Tailored strategies can complement existing vertical HIV transmission programs.
Conclusions:
- Countries can end AIDS in children through adapted case-finding, optimized testing timing, and appropriate technologies.
- Political will, strategic planning, funding, and innovation are essential for success.
- Successful elimination of pediatric AIDS is achievable, as demonstrated by several countries.
Introduction:
Though considerable effort and investment has significantly increased the proportion of pregnant women living with HIV accessing lifesaving antiretroviral therapy and lowered the prevalence of vertical HIV transmission, more than 70,000 children die each year due to AIDS-related deaths, and nearly half of the 1.4 million children living with HIV are not receiving antiretroviral treatment (ART). Improving case-finding and identification of children acquiring HIV and accelerating linkage to ART will be fundamental to end AIDS in children.
Discussion:
A variety of existing infant and child case-finding strategies could be tailored by countries to complement testing within vertical HIV transmission programmes, including establishing the HIV exposure status of sick infants and children attending malnutrition and inpatient wards and children accessing vaccines, as well as out-of-facility strategies such as community and family-based testing. Because the risk of HIV acquisition is persistent throughout pregnancy, delivery and breastfeeding, repeated testing throughout the exposure period and especially after cessation of breastfeeding will be critical in capturing HIV acquisitions as early as possible. Immediate or rapid linkage to ART is now possible through using same-day point-of-care testing technologies.
Conclusions:
As countries aim to end AIDS in children, adapted and nuanced strategies for case-finding, test timing and the technologies used should be leveraged to meet the needs of each setting and country. Several countries have shown us that it is possible to end AIDS; however, it requires political will, strategic thinking, funding, prioritization and creative innovations.
Related Concept Videos
Pharmacokinetics in Pediatric Patients: Drug Excretion
Immunodeficiency Diseases
There are three main causes of immunodeficiency disorders...
Sexually Transmitted Infections
Cryptococcal Meningitis
Retrovirus Life Cycles
Automated Microbial Diagnostics

